S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 41 to 80 of 94

Issue Date	Title / Author(s) / Citation	File
2011-08	Prognostic Significance of HLA Class I Expressing in Gastric Carcinoma Defined by Monoclonal Anti-Pan HLA Class I Antibody, EMR8-5 Lee, Hae-Wan; Min, Soo Kee; Ju, Young-Su; Sung, Joohon; Lim, Man Sup; Yang, Dae Hyun; Lee, Bong Hwa Journal of Gastrointestinal Surgery, Vol.15 No.8, pp.1336-1343	DOI
2011-12	Phase II study of sunitinib as second-line treatment for advanced gastric cancer Bang, Yung-Jue; Kang, Yoon-Koo; Kang, Won K.; Boku, Narikazu; Chung, Hyun C.; Chen, Jen-Shi; Doi, Toshihiko; Sun, Yan; Shen, Lin; Qin, Shukui; Ng, Wai-Tong; Tursi, Jennifer M.; Lechuga, Maria J.; Lu, Dongrui Ray; Ruiz-Garcia, Ana; Sobrero, Alberto Investigational New Drugs, Vol.29 No.6, pp.1449-1458	DOI
2012-08	Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer Park, Jinah; Park, Eunju; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo-Ho; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.4, pp.1404-1412	DOI
2012-10	Bisphosphonate use and gastrointestinal tract cancer risk: Meta-analysis of observational studies Oh, Yun Hwan; Yoon, Chan; Park, Sang Min WORLD JOURNAL OF GASTROENTEROLOGY Vol.18 No.40, pp. 5779-5788	view file DOI
2012-10	Bisphosphonate use and gastrointestinal tract cancer risk: Meta-analysis of observational studies Oh, Yun Hwan; Yoon, Chan; Park, Sang Min World Journal of Gastroenterology, Vol.18 No.40, pp.5779-5788	DOI
2013-02	Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis Yoon, Jae Moon; Son, Ki Young; Eom, Chun Sick; Durrance, Daniel; Park, Sang Min World Journal of Gastroenterology, Vol.19 No.6, pp.936-945	DOI
2013-02	Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis Yoon, Jae Moon; Son, Ki Young; Eom, Chun Sick; Durrance, Daniel; Park, Sang Min World Journal Gastroenterol Vol.19 No.6, pp. 936-945	DOI
2013-06	Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer Kim, Jin Won; Cho, Hyun Jin; Kim, Miso; Lee, Kyung-Hun; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk-Joon; Im, Seock-Ah; Kim, Tae-You; Yang, Han-Kwang; Kim, Woo Ho; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.71 No.6, pp.1435-1443	DOI
2013-07	OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.335 No.1, pp.145-152	DOI
2013-09	Adjuvant and Neoadjuvant Therapy for Gastric Cancer Oh, Do-Youn; Bang, Yung-Jue Current Treatment Options in Oncology, Vol.14 No.3, pp.311-320	DOI
2013-10	Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival Kang, Eun Joo; Im, Seock-Ah; Oh, Do-Youn; Han, Sae-Won; Kim, Jin-Soo; Choi, In Sil; Kim, Jin Won; Kim, Yu Jung; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Lee, Keun-Wook Gastric Cancer, Vol.16 No.4, pp.581-589	DOI
2014-02	Spleen-Preserving Lymphadenectomy Versus Splenectomy in Laparoscopic Total Gastrectomy for Advanced Gastric Cancer 손상용	view file
2014-07	Quality of Life in the Trastuzumab for Gastric Cancer Trial Satoh, Taroh; Bang, Yung-Jue; Gotovkin, Evgeny A.; Hamamoto, Yasuo; Kang, Yoon-Koo; Moiseyenko, Vladimir M.; Ohtsu, Atsushi; Van Cutsem, Eric; Al-Sakaff, Nedal; Urspruch, Alexa; Hill, Julie; Weber, Harald A.; Chung, Hyun-Cheol Oncologist, Vol.19 No.7, pp.712-719	DOI
2015-02	Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication. 송영석	view file
2015-02	Studies of synergistic antibody combination for treatment of patients with HER2-positive cancer 고봉국	view file
2015-05	Determinants of gastric cancer screening attendance in Korea: a multi-level analysis Chang, Yunryong; Cho, Belong; Son, Ki Young; Shin, Dong Wook; Shin, Hosung; Yang, Hyung-Kook; Shin, Aesun; Yoo, Keun-Young BMC Cancer, 15(1):336	view file DOI
2015-06	A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer Kim, Jin Won; Choi, In Sil; Kim, Yu Jung; Lee, Kyung-Hun; Lee, Keun-Wook; Kim, Tae-Yong; Han, Sae-Won; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Im, Seock-Ah; Oh, Do-Youn Cancer Chemotherapy and Pharmacology, Vol.75 No.6, pp.1175-1182	DOI
2015-07	HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Van Cutsem, Eric; Bang, Yung-Jue; Feng-Yi, Feng; Xu, Jian M.; Lee, Keun-Wook; Jiao, Shun-Chang; Chong, Jorge Leon; Lopez-Sanchez, Roberto I.; Price, Timothy; Gladkov, Oleg; Stoss, Oliver; Hill, Julie; Ng, Vivian; Lehle, Michaela; Thomas, Marlene; Kiermaier, Astrid; Rueschoff, Josef Gastric Cancer, Vol.18 No.3, pp.476-484	DOI
2016-02	Resveratrol Suppresses Gastric Cancer Cell Growth and Proliferation through Inhibition PIM-1 Kinase Activity 김수진	view file
2016-04	Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer Ock, Chan-Young; Oh, Do-Youn; Lee, Joongyub; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Gastric Cancer, Vol.19 No.2, pp.597-606	DOI
2016-04	Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications Ock, Chan-Young; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.19 No.2, pp.421-430	DOI
2016-06	c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer Choi, Youngsun; Park, Jinju; Choi, Yiseul; Ko, Young San; Yu, Da-Ae; Kim, Younghoon; Pyo, Jung-Soo; Jang, Bo Gun; Kim, Min A.; Kim, Woo Ho; Lee, Byung Lan BMC Gastroenterology, 16(1):59	view file DOI
2016-10	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer Oh, Do-Youn; Lee, Kewn-Wook; Cho, Jae Yong; Kang, Won Ki; Im, Seock-Ah; Kim, Jin Won; Bang, Yung-Jue Gastric Cancer, Vol.19 No.4, pp.1095-1103	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-08	Identification of potential serum protein biomarkers for recurrence in gastric cancer patients using a quantitative multiple reaction monitoring approach 조병규	view file
2018-02	Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients 윤수미	view file
2018-02	Clinical efficacy of endoscopic ultrasonography for decision of treatment strategy of gastric cancer 김정	view file
2018-03	Long-term trastuzumab (Herceptin (R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer Mueller, Volkmar; Clemens, Michael; Jassem, Jacek; Al-Sakaff, Nedal; Auclair, Petra; Nuesch, Eveline; Holloway, Debbie; Shing, Mona; Bang, Yung-Jue BMC Cancer, Vol.18, p. 295	view file DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2019-02	A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer Bang, Y. -J.; Kang, Y. -K.; Ng, M.; Chung, H. C.; Wainberg, Z. A.; Gendreau, S.; Chan, W. Y.; Xu, N.; Maslyar, D.; Meng, R.; Chau, I; Ajani, J. A. European Journal of Cancer, Vol.108, pp.17-24	DOI
2019-05	Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer Shin, Yun-Joo; Kim, Younghoon; Wen, Xianyu; Cho, Nam-Yun; Lee, Sun; Kim, Woo Ho; Kang, Gyeong Hoon Clinical Epigenetics. 11(1):77	view file DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2019-08	Visualization of NIR-fluorescence labeled Affibody and Trastuzumab in HER2 overexpressed Gastric CancerVisualization of NIR-fluorescence labeled Affibody and Trastuzumab in HER2 overexpressed Gastric Cancer 정경윤	view file link
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-11	A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer Kim, Tae-Yong; Han, Hye Sook; Lee, Keun-Wook; Zang, Dae Young; Rha, Sun Young; Park, Young lee; Kim, Jin-Soo; Lee, Kyung-Hun; Park, Se Hoon; Song, Eun-Kee; Jung, Soo-A; Lee, NaMi; Kim, Yeul Hong; Cho, Jae Yong; Bang, Yung-Jue Gastric Cancer, Vol.22 No.6, pp.1206-1214	DOI
2020	The proposal of a new TNM classification of gastric cancer : Focusing on pN3b and cytology positive (CY1) disease 김사홍	link
2020	Predictive model for fluorodeoxyglucose avidity in gastric cancer using patient-derived xenograft model as an imaging biomarker 배성우	view file link
2020-07	microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2 Min, Jimin; Han, Tae-Su; Sohn, Yoojin; Shimizu, Takahiro; Choi, Boram; Bae, Seong-Woo; Hur, Keun; Kong, Seong-Ho; Suh, Yun-Suhk; Lee, Hyuk-Joon; Kim, Jang-Seong; Min, Jeong-Ki; Kim, Woo-Ho; Kim, V. Narry; Choi, Eunyoung; Goldenring, James R.; Yang, Han-Kwang Gastric Cancer, Vol.23 No.4, pp.600-613	DOI
2020-08	Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity Kim, Sujin; Kim, Wonki; Kim, Do-Hee; Jang, Jeong-Hoon; Kim, Su-Jung; Park, Sin-Aye; Hahn, Hyunggu; Han, Byung Woo; Na, Hye-Kyung; Chun, Kyung-Soo; Choi, Bu Young; Surh, Young-Joon Archives of Biochemistry and Biophysics, Vol.689, p. 108413	view file DOI

1 2 3